Does DABIGATRAN ETEXILATE Cause Coagulopathy? 718 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 718 reports of Coagulopathy have been filed in association with DABIGATRAN ETEXILATE (dabigatran etexilate). This represents 1.9% of all adverse event reports for DABIGATRAN ETEXILATE.
718
Reports of Coagulopathy with DABIGATRAN ETEXILATE
1.9%
of all DABIGATRAN ETEXILATE reports
222
Deaths
631
Hospitalizations
How Dangerous Is Coagulopathy From DABIGATRAN ETEXILATE?
Of the 718 reports, 222 (30.9%) resulted in death, 631 (87.9%) required hospitalization, and 85 (11.8%) were considered life-threatening.
Is Coagulopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DABIGATRAN ETEXILATE. However, 718 reports have been filed with the FAERS database.
What Other Side Effects Does DABIGATRAN ETEXILATE Cause?
Gastrointestinal haemorrhage (4,081)
Cerebrovascular accident (2,175)
Fall (1,786)
Ischaemic stroke (1,581)
Anaemia (1,412)
Haemorrhage (1,324)
Death (1,025)
Rectal haemorrhage (964)
Cerebral haemorrhage (946)
Upper gastrointestinal haemorrhage (861)
What Other Drugs Cause Coagulopathy?
RIVAROXABAN (1,002)
ACETAMINOPHEN (977)
ASPIRIN (674)
WARFARIN (589)
METHOTREXATE (414)
VINCRISTINE (275)
APIXABAN (271)
CYCLOPHOSPHAMIDE (240)
PREDNISONE (228)
IBUPROFEN (227)
Which DABIGATRAN ETEXILATE Alternatives Have Lower Coagulopathy Risk?
DABIGATRAN ETEXILATE vs DABRAFENIB
DABIGATRAN ETEXILATE vs DABRAFENIB\TRAMETINIB
DABIGATRAN ETEXILATE vs DACARBAZINE
DABIGATRAN ETEXILATE vs DACLATASVIR
DABIGATRAN ETEXILATE vs DACLIZUMAB